Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,052 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pulmonary hypertension in adults with congenital heart defects (ACHDs) in light of the 2022 ESC PAH guidelines-part II: supportive therapy, special situations (pregnancy, contraception, non-cardiac surgery), targeted pharmacotherapy, organ transplantation, special management (shunt lesion, left ventricular disease, univentricular hearts), interventions, intensive care, ACHD follow-up, future perspective.
Kaemmerer H, Diller GP, Dähnert I, Achenbach S, Eichstaedt CA, Eicken A, Freiberger A, Freilinger S, Geiger R, Gorenflo M, Grünig E, Hager A, Huntgeburth M, Kaemmerer-Suleiman AS, Kozlik-Feldmann R, Lammers AE, Nagdyman N, Michel S, Schmidt KH, Suleiman M, Uebing A, von Scheidt F, Herberg U, Apitz C. Kaemmerer H, et al. Among authors: achenbach s. Cardiovasc Diagn Ther. 2024 Oct 31;14(5):921-934. doi: 10.21037/cdt-24-167. Epub 2024 Oct 22. Cardiovasc Diagn Ther. 2024. PMID: 39513142 Free PMC article. Review.
Pulmonary hypertension in adults with congenital heart defects (ACHDs)-in light of the 2022 ESC PAH guidelines-part I: definition, epidemiology, classification, diagnostics, genetics, risk stratification and follow-up, gender aspects.
Kaemmerer H, Diller GP, Dähnert I, Achenbach S, Eichstaedt CA, Eicken A, Freiberger A, Freilinger S, Geiger R, Gorenflo M, Grünig E, Hager A, Huntgeburth M, Kaemmerer-Suleiman AS, Kozlik-Feldmann R, Lammers AE, Nagdyman N, Michel S, Schmidt KH, Suleiman M, Uebing A, von Scheidt F, Herberg U, Apitz C. Kaemmerer H, et al. Among authors: achenbach s. Cardiovasc Diagn Ther. 2024 Oct 31;14(5):935-948. doi: 10.21037/cdt-24-148. Epub 2024 Oct 22. Cardiovasc Diagn Ther. 2024. PMID: 39513141 Free PMC article. Review.
Patient-Specific Myocardial Infarction Risk Thresholds From AI-Enabled Coronary Plaque Analysis.
Miller RJH, Manral N, Lin A, Shanbhag A, Park C, Kwiecinski J, Killekar A, McElhinney P, Matsumoto H, Razipour A, Grodecki K, Kwan AC, Han D, Kuronuma K, Flores Tomasino G, Geers J, Goeller M, Marwan M, Gransar H, Tamarappoo BK, Cadet S, Cheng VY, Achenbach S, Nicholls SJ, Wong DT, Chen L, Cao JJ, Berman DS, Dweck MR, Newby DE, Williams MC, Slomka PJ, Dey D. Miller RJH, et al. Among authors: achenbach s. Circ Cardiovasc Imaging. 2024 Oct;17(10):e016958. doi: 10.1161/CIRCIMAGING.124.016958. Epub 2024 Sep 30. Circ Cardiovasc Imaging. 2024. PMID: 39405390
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism.
Koehler AB, Rabe KG, Crusan DJ, Call TG, Achenbach SJ, Hampel PJ, Kenderian SS, Leis JF, Wang Y, Muchtar E, Tsang M, Hilal T, Parrondo R, Bailey KR, Ding W, Bailen R, Schwager SM, Shi M, Hanson CA, Slager SL, Kay NE, Ashrani AA, Parikh SA. Koehler AB, et al. Among authors: achenbach sj. J Thromb Haemost. 2025 Jan;23(1):149-157. doi: 10.1016/j.jtha.2024.08.029. Epub 2024 Sep 27. J Thromb Haemost. 2025. PMID: 39343103
1,052 results